Institute of Medicine, Chung Shan Medical University, 40201, Taichung, Taiwan.
School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
BMC Public Health. 2019 Jul 31;19(1):1025. doi: 10.1186/s12889-019-7160-z.
The mortality-to-incidence ratio (MIR) is a marker that reflects the clinical outcome of cancer treatment. MIR as a prognostic marker is more accessible when compared with long-term follow-up survival surveys. Theoretically, countries with good health care systems would have favorable outcomes for cancer; however, no report has yet demonstrated an association between gallbladder cancer MIR and the World's Health System ranking.
We used linear regression to analyze the correlation of MIRs with the World Health Organization (WHO) rankings and total expenditures on health/gross domestic product (e/GDP) in 57 countries selected according to the data quality.
The results showed high crude rates of incidence/mortality but low MIR in more developed regions. Among continents, Europe had the highest crude rates of incidence/mortality, whereas the highest age-standardized rates (ASR) of incidence/mortality were in Asia. The MIR was lowest in North America and highest in Africa (0.40 and 1.00, respectively). Furthermore, favorable MIRs were correlated with good WHO rankings and high e/GDP (p = 0.01 and p = 0.030, respectively).
The MIR variation for gallbladder cancer is therefore associated with the ranking of the health system and the expenditure on health.
病死率比(MIR)是反映癌症治疗临床结果的指标。与长期随访生存调查相比,MIR 作为预后标志物更容易获得。理论上,医疗保健系统良好的国家在癌症方面的结果应该更好;然而,目前尚无报告表明胆囊癌 MIR 与世界卫生系统排名之间存在关联。
我们使用线性回归分析了 57 个根据数据质量选择的国家的 MIR 与世界卫生组织(WHO)排名和卫生总支出/国内生产总值(e/GDP)之间的相关性。
结果表明,在较发达地区,发病率/死亡率的粗率较高,但 MIR 较低。在各大洲中,欧洲的发病率/死亡率最高,而亚洲的发病率/死亡率标准化率(ASR)最高。北美 MIR 最低,非洲最高(分别为 0.40 和 1.00)。此外,良好的 MIR 与良好的 WHO 排名和高 e/GDP 相关(p=0.01 和 p=0.030,分别)。
因此,胆囊癌 MIR 的变化与卫生系统的排名和卫生支出有关。